BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 20027112)

  • 21. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
    Long X; Xiong J; Mo Z; Zhang Q; Jin P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
    Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
    Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Segmental neurofibromatosis in childhood.
    Listernick R; Mancini AJ; Charrow J
    Am J Med Genet A; 2003 Aug; 121A(2):132-5. PubMed ID: 12910491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognizing an index case of type 1 neurofibromatosis.
    Pollack CV; Pender ES
    Am Fam Physician; 1992 Feb; 45(2):623-8. PubMed ID: 1739047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis 1: clinical manifestations and diagnostic criteria.
    Friedman JM
    J Child Neurol; 2002 Aug; 17(8):548-54; discussion 571-2, 646-51. PubMed ID: 12403552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
    Colman SD; Williams CA; Wallace MR
    Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Neurofibromatoses. Part 1: NF1.
    Lu-Emerson C; Plotkin SR
    Rev Neurol Dis; 2009; 6(2):E47-53. PubMed ID: 19587630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.